Trial Profile
A phase III trial to assess insulin glargine, vs NPH insulin, in combination with oral anti-diabetics in patients with type 2 diabetes mellitus who were pretreated with oral anti-diabetics alone, or insulin + oral anti-diabetics.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Nov 2014
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 05 Nov 2010 New trial record.